McDermott MP - Search Results

1

Mexiletine is an effective antimyotonia treatment in myotonic dystrophy type 1.

Logigian EL, Martens WB, Moxley RT 4th, McDermott MP, Dilek N, Wiegner AW, Pearson AT, Barbieri CA, Annis CL, Thornton CA, Moxley RT 3rd. Logigian EL, et al. Among authors: mcdermott mp. Neurology. 2010 May 4;74(18):1441-8. doi: 10.1212/WNL.0b013e3181dc1a3a. Neurology. 2010. PMID: 20439846 Free PMC article. Clinical Trial.

2

Factors predictive of the need for levodopa therapy in early, untreated Parkinson's disease. The Parkinson Study Group.

McDermott MP, Jankovic J, Carter J, Fahn S, Gauthier S, Goetz CG, Golbe LI, Koller W, Lang AE, Olanow CW, et al. McDermott MP, et al. Arch Neurol. 1995 Jun;52(6):565-70. doi: 10.1001/archneur.1995.00540300037010. Arch Neurol. 1995. PMID: 7763203 Clinical Trial.

3

Facioscapulohumeral muscular dystrophy (FSHD): design of natural history study and results of baseline testing. FSH-DY Group.

Tawil R, McDermott MP, Mendell JR, Kissel J, Griggs RC. Tawil R, et al. Among authors: mcdermott mp. Neurology. 1994 Mar;44(3 Pt 1):442-6. doi: 10.1212/wnl.44.3_part_1.442. Neurology. 1994. PMID: 8145913

4

A controlled trial of deprenyl in children with Tourette's syndrome and attention deficit hyperactivity disorder.

Feigin A, Kurlan R, McDermott MP, Beach J, Dimitsopulos T, Brower CA, Chapieski L, Trinidad K, Como P, Jankovic J. Feigin A, et al. Among authors: mcdermott mp. Neurology. 1996 Apr;46(4):965-8. doi: 10.1212/wnl.46.4.965. Neurology. 1996. PMID: 8780073 Clinical Trial.

5

A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Tawil R, McDermott MP, Pandya S, King W, Kissel J, Mendell JR, Griggs RC. Tawil R, et al. Among authors: mcdermott mp. Neurology. 1997 Jan;48(1):46-9. doi: 10.1212/wnl.48.1.46. Neurology. 1997. PMID: 9008492

6

Quantitative assessment of sustained-release 4-aminopyridine for symptomatic treatment of multiple sclerosis.

Schwid SR, Petrie MD, McDermott MP, Tierney DS, Mason DH, Goodman AD. Schwid SR, et al. Among authors: mcdermott mp. Neurology. 1997 Apr;48(4):817-21. doi: 10.1212/wnl.48.4.817. Neurology. 1997. PMID: 9109861 Clinical Trial.

7

The measurement of ambulatory impairment in multiple sclerosis.

Schwid SR, Goodman AD, Mattson DH, Mihai C, Donohoe KM, Petrie MD, Scheid EA, Dudman JT, McDermott MP. Schwid SR, et al. Among authors: mcdermott mp. Neurology. 1997 Nov;49(5):1419-24. doi: 10.1212/wnl.49.5.1419. Neurology. 1997. PMID: 9371932

8

Pilot trial of albuterol in facioscapulohumeral muscular dystrophy. FSH-DY Group.

Kissel JT, McDermott MP, Natarajan R, Mendell JR, Pandya S, King WM, Griggs RC, Tawil R. Kissel JT, et al. Among authors: mcdermott mp. Neurology. 1998 May;50(5):1402-6. doi: 10.1212/wnl.50.5.1402. Neurology. 1998. PMID: 9595995 Clinical Trial.

9

Neuropsychologic status in multiple sclerosis after treatment with glatiramer.

Weinstein A, Schwid SR, Schiffer RB, McDermott MP, Giang DW, Goodman AD. Weinstein A, et al. Among authors: mcdermott mp. Arch Neurol. 1999 Mar;56(3):319-24. doi: 10.1001/archneur.56.3.319. Arch Neurol. 1999. PMID: 10190822 Clinical Trial.

10

Randomized trial of the platelet-activating factor antagonist lexipafant in HIV-associated cognitive impairment. Neurological AIDS Research Consortium.

Schifitto G, Sacktor N, Marder K, McDermott MP, McArthur JC, Kieburtz K, Small S, Epstein LG. Schifitto G, et al. Among authors: mcdermott mp. Neurology. 1999 Jul 22;53(2):391-6. doi: 10.1212/wnl.53.2.391. Neurology. 1999. PMID: 10430432 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page